Creating four-chambered hearts using organoid fusions
Official title: Generation of four-chambered hearts through organoid fusions
Funded at University of Pittsburgh at Pittsburgh · NIH-10471475 · Data updated 2026-11-12
This study is exploring a new way to create realistic, functioning hearts from special cells taken from patients, especially those with congenital heart defects, to help us better understand these heart issues and improve treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $954,000 |
| NIH project number | 4DP2HL163745-02 |
| Project ID | NIH-10471475 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with congenital heart defects or those who are carriers of genetic mutations associated with these conditions.
✕Less likely to help
Patients without congenital heart defects or those not carrying relevant genetic mutations may not benefit from this research.
What this research studies
This research investigates a novel method to generate functional four-chambered hearts by fusing organoids derived from human induced pluripotent stem cells (hiPSCs). The approach aims to overcome the limitations of current models for congenital heart defects (CHDs) by creating anatomically accurate heart structures, including chambers, valves, and septum. By using organoids that mimic human heart development, the research seeks to better understand the mechanisms behind CHDs and improve modeling for these conditions. Patients' hiPSC lines, especially those with known CHD mutations, will be utilized to create these organoid fusions, providing a more relevant platform for studying heart malformations.
Why it matters
Potential benefit: If successful, this research could lead to improved models for congenital heart defects, enhancing understanding and treatment options for affected patients.
How similar studies have gone: While organoid technology is a growing field, this specific approach of generating four-chambered hearts through organoid fusions is novel and has not been extensively tested in prior research.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Li, Guang — University of Pittsburgh at Pittsburgh
- Study coordinator: Li, Guang
Related research
Other NIH-funded projects on the same topics.
-
Elastomeric membranes for safer pelvic organ prolapse repair
A new 3D-printed elastomeric membrane made from polycarbonate urethane is being tested to replace stiff polypropylene meshes for pelvic organ prolapse in women, aiming to reduce complications.
-
Role of hyaluronan in egg development and ovarian reserve
This grant studies how the hyaluronan matrix in the ovary affects the aging of the female reproductive system and the pool of eggs available.
-
Regulatory switches that control imprinting in early human development
This grant studies how certain genes stay “one-copy” active in early development and what goes wrong in assisted reproduction, with a focus on imprinting disorders.
-
Identifying molecular signs of imprinting errors linked to fertility treatments
This grant studies how assisted reproductive technologies may cause imprinting errors in embryos and how these errors relate to certain birth conditions, with implications for families using infertility treatments.
-
Bioadhesive vaginal film for 7-day protection against HIV, HSV, and pregnancy
A vaginal film that slowly releases antibodies to prevent HIV, HSV, and unintended pregnancy for about a week from a single use.
-
Spermatogonial stem cell transplantation and culture in patients
Researchers are testing a way to transplant or grow sperm-producing cells back in boys and men who stored tissue before cancer treatment, to help them have biological children in the future.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.